Pershing Edwardinsider trades
In SEC Form 4 filings, Pershing Edward is listed as CEO of Provectus Biopharmaceuticals, Inc. (PVCT). Pershing Edward reported no open-market purchases or sales in the last 90 days. The latest Form 4 transaction on record was filed on Oct 23.
Companies and roles
| Company | Role | Transactions | Last filed |
|---|---|---|---|
| PVCTProvectus Biopharmaceuticals, Inc. | CEO | 14 | Oct 23 |
Cluster buys
No cluster buy in the last 90 days included a purchase by this insider (two or more insiders buying within 14 days).
Form 4 historysince 2026-08-26
| Company | Traded | Filed | Type | Shares | Price | Value | Owned after | 10b5-1 plan | Filing |
|---|---|---|---|---|---|---|---|---|---|
| PVCTProvectus Biopharmaceuticals, Inc. | Oct 23 | Oct 23 | M · derivative | 7,599 | $2.86 | $21,748 | not reported | No | Form 4 |
| PVCTProvectus Biopharmaceuticals, Inc. | Oct 23 | Oct 23 | M · derivative | 7,599 | $0.00 | $0 | 3,006,133 | No | Form 4 |
| PVCTProvectus Biopharmaceuticals, Inc. | Oct 10 | Oct 13 | M · derivative | 22,609 | $2.86 | $64,707 | not reported | No | Form 4 |
| PVCTProvectus Biopharmaceuticals, Inc. | Oct 10 | Oct 13 | M · derivative | 22,609 | $0.00 | $0 | 2,998,534 | No | Form 4 |
| PVCTProvectus Biopharmaceuticals, Inc. | Oct 3 | Oct 5 | M · derivative | 13,216 | $2.86 | $37,824 | not reported | No | Form 4 |
| PVCTProvectus Biopharmaceuticals, Inc. | Oct 3 | Oct 5 | M · derivative | 13,216 | $0.00 | $0 | 2,975,925 | No | Form 4 |
| PVCTProvectus Biopharmaceuticals, Inc. | Sep 18 | Sep 18 | M · derivative | 13,216 | $2.86 | $37,824 | not reported | No | Form 4 |
| PVCTProvectus Biopharmaceuticals, Inc. | Sep 18 | Sep 18 | M · derivative | 13,216 | $0.00 | $0 | 2,962,709 | No | Form 4 |
| PVCTProvectus Biopharmaceuticals, Inc. | Sep 11 | Sep 11 | M · derivative | 13,216 | $2.86 | $37,824 | not reported | No | Form 4 |
| PVCTProvectus Biopharmaceuticals, Inc. | Sep 11 | Sep 11 | M · derivative | 13,216 | $0.00 | $0 | 2,949,493 | No | Form 4 |
| PVCTProvectus Biopharmaceuticals, Inc. | Sep 4 | Sep 8 | M · derivative | 11,328 | $2.86 | $32,421 | not reported | No | Form 4 |
| PVCTProvectus Biopharmaceuticals, Inc. | Sep 4 | Sep 8 | M · derivative | 11,328 | $0.00 | $0 | 2,936,277 | No | Form 4 |
| PVCTProvectus Biopharmaceuticals, Inc. | Aug 26 | Aug 26 | M · derivative | 11,328 | $2.86 | $32,421 | not reported | No | Form 4 |
| PVCTProvectus Biopharmaceuticals, Inc. | Aug 26 | Aug 26 | M · derivative | 11,328 | $0.00 | $0 | 2,924,949 | No | Form 4 |
Published from this insider's public Form 4 filings on SEC EDGAR; the name is shown as filed. Named in a filing and want this page removed? See the privacy policy.